Chemoinformaics analysis of Cyclopentane, 1,2,4-trimethyl-, trans,cis-
| Molecular Weight | 112.216 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 5 |
| Exact Molecular Weight | 112.125 | nRing | 1 |
| Solubility: LogS | -4.251 | nHRing | 0 |
| Solubility: LogP | 3.541 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 24.0287 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.452 |
| Synth | 3.015 |
| Natural Product Likeliness | 1.062 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.352 |
| MDCK | 0.000021 |
| BBB | 0.957 |
| PPB | 0.875934 |
| VDSS | 2.017 |
| FU | 0.106769 |
| CYP1A2-inh | 0.842 |
| CYP1A2-sub | 0.79 |
| CYP2c19-inh | 0.224 |
| CYP2c19-sub | 0.858 |
| CYP2c9-inh | 0.599 |
| CYP2c9-sub | 0.568 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.148 |
| CYP3a4-sub | 0.304 |
| CL | 14.821 |
| T12 | 0.287 |
| hERG | 0.014 |
| Ames | 0.012 |
| ROA | 0.049 |
| SkinSen | 0.261 |
| Carcinogencity | 0.127 |
| EI | 0.991 |
| Respiratory | 0.172 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.954681 |